Strategies to Facilitate Interorganizational Collaboration in County-Level Opioid Overdose Prevention and Response: A Qualitative Analysis. [PDF]
Dickson-Gomez J +4 more
europepmc +1 more source
Abstract Introduction Although state, federal, and professional guidelines stipulate the need for informed consent for toxicology testing during pregnancy, consent is often inadequately obtained. The objective of this study was to explore birthing person and obstetric clinician experiences with consent for toxicology testing during pregnancy.
Leah N. Schwartz +7 more
wiley +1 more source
Exploring modifiable neighborhood risk factors for fatal opioid overdose: a case-control study in two US cities. [PDF]
Nesoff ED +3 more
europepmc +1 more source
Methods of Suicide Used by People With Cancer: A Scoping Review
ABSTRACT Background Individuals diagnosed with cancer are at increased risk of suicide compared to the general population. Access to means is a key volitional risk factor for suicide and represents a modifiable target for prevention at a population level.
Doireann Ni Dhalaigh +5 more
wiley +1 more source
Racial and sex disparities in inpatient outcomes of patients with opioid overdose: a nationwide analysis. [PDF]
Quazi MA +8 more
europepmc +1 more source
Abstract The rising rate of drug‐related deaths in the United States, largely driven by fentanyl, requires timely and accurate surveillance. However, critical overdose data are often buried in free‐text coroner reports, leading to delays and information loss when coded into ICD (International Classification of Disease)‐10 classifications.
Arthur J. Funnell +8 more
wiley +1 more source
Opioid Overdose Reversal With Nalmefene Nasal Spray: A Case Report. [PDF]
Sucher M, Emmans L.
europepmc +1 more source
Compiling Comprehensive Databases for Opioid Overdose Monitoring in a Fragmented Health Care System
Health Services Research, Volume 61, Issue 3, June 2026.
Dominic Hodgkin, Traci C. Green
wiley +1 more source
Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022
Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) or “ecstasy,” is a commonly used drug worldwide, including in New Zealand, where 4.8% of the population aged 15 years or over reported using it in a 2023/2024 survey. This study provides additional insights on MDMA prevalence data in New Zealand by reporting toxicology data from Coronial and driving ...
Thomas J. Sheehan +4 more
wiley +1 more source
From law enforcement to public safety: Police officer experiences of naloxone administration to reverse opioid overdose in New York City. [PDF]
Allen B, Harocopos A.
europepmc +1 more source

